Nyrada (ASX:NYR) Days Payable: 0.00 (As of Dec. 2025)


ASX:NYR Nyrada Inc ASX:NYR
25 GF Score
Price A$0.43
! 1 Warning Sign
View Full Analysis

What is Nyrada Days Payable?

Nyrada ASX:NYR +4.88% 25 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates ASX:NYR with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 701 Biotechnology companies, Nyrada ranks worse than 142653.21% on this metric.

Nyrada's average Accounts Payable for the six months ended in Dec. 2025 was A$0.61 Mil. Nyrada's Cost of Goods Sold for the six months ended in Dec. 2025 was A$0.00 Mil.

The historical rank and industry rank for Nyrada's Days Payable or its related term are showing as below:

ASX:NYR's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Nyrada's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Nyrada Days Payable Historical Data

* Premium members only.

The historical data trend for Nyrada's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nyrada Days Payable Chart

Nyrada Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nyrada Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:NYR vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Nyrada's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nyrada Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nyrada's Days Payable distribution charts can be found below:

* The bar in red indicates where Nyrada's Days Payable falls into.


ASX:NYR
25GF Score
Nyrada Inc ASX:NYR
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nyrada Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Nyrada's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as

Days Payable (A: Jun. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2024 ) + Accounts Payable (A: Jun. 2025 )) / count ) / Cost of Goods Sold (A: Jun. 2025 )*Days in Period
=( (0.118 + 0.909) / 2 ) / 0*365
=0.5135 / 0*365
=N/A

Nyrada's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.909 + 0.301) / 2 ) / 0*365 / 2
=0.605 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Nyrada (ASX:NYR) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nyrada and its competitors. According to the industry distribution chart, Nyrada ranks #999999 out of 701 companies in the Biotechnology industry.
Is Nyrada's Days Payable too high?
Nyrada's current Days Payable is 0.00. Based on the distribution chart, Nyrada ranks #999999 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nyrada has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Nyrada's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nyrada ranks #999999 out of 701 companies for Days Payable. This places Nyrada in the lower half of its industry. The industry median Days Payable is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nyrada and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nyrada's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nyrada stock overvalued right now?
Nyrada (ASX:NYR) has a current Days Payable of 0.00. The current Days Payable is 0.00. Nyrada's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nyrada (ASX:NYR), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nyrada Business Description

Address 180 George Street, Sydney Place, Level 22/23, Salesforce Tower, Sydney, NSW, AUS, 2000
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. It operates in one segment: research and development of drugs focusing on small molecules with potential therapeutic benefit in areas of medical needs. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.
25GF Score

Get the complete analysis for ASX:NYR

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.43
Price